Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis.
Subodh J SaggiSridesh NathRoshni CulasSeema ChittalaeAaliya BurzaMaya SrinivasanRishard AbdulBenjamin SilverAlnardo LoraIshmam IbtidaTanuj ChokshiVioleta CapricAmmar MohamedSamrat WorahJie OuYangPatrick GeraghtyAngelika GruessnerMoro O SalifuPublished in: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2020)
In AA COVID-19 positive patients with ARDS and AKI, IV methylprednisolone lowered the incidence of mortality and improved the likelihood of renal and lung function recovery. Further investigation with a randomized control trial of corticosteroids is warranted.
Keyphrases
- lung function
- african american
- high dose
- coronavirus disease
- risk factors
- cystic fibrosis
- chronic obstructive pulmonary disease
- respiratory syndrome coronavirus
- air pollution
- sars cov
- acute kidney injury
- acute respiratory distress syndrome
- cardiovascular events
- extracorporeal membrane oxygenation
- mechanical ventilation